{"id":1902,"date":"2021-01-14T00:00:00","date_gmt":"2021-01-13T23:00:00","guid":{"rendered":"http:\/\/idlbiotech.com\/?p=1902"},"modified":"2021-05-26T09:02:28","modified_gmt":"2021-05-26T07:02:28","slug":"idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker","status":"publish","type":"post","link":"https:\/\/idldiagnostics.com\/se\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/","title":{"rendered":"IDL Biotech forts\u00e4tter sitt arbete med att automatisera TPS\u00ae tum\u00f6rmark\u00f6r"},"content":{"rendered":"

Som tidigare informerats tecknade IDL Biotech i slutet av 2019 ett samarbetsavtal med det kinesiska f\u00f6retaget Zecen Biotech g\u00e4llande automatisering av tum\u00f6rmark\u00f6ren TPS\u00ae p\u00e5 samtliga Zecen Biotechs instrument. Utvecklingsprojektet har fortl\u00f6pt mycket v\u00e4l och den f\u00f6rsta fasen har genomf\u00f6rts. D\u00e4rmed p\u00e5b\u00f6rjas nu den sista fasen inf\u00f6r lansering. F\u00f6rhoppningen \u00e4r att produkten ska finnas p\u00e5 den kinesiska marknaden vid utg\u00e5ngen av 2021.<\/p>\n

L\u00e4s hela pressmeddelandet h\u00e4r<\/a> (svenska)<\/p>","protected":false},"excerpt":{"rendered":"

As previously informed, at the end of 2019, IDL Biotech signed a cooperation agreement with the Chinese company Zecen Biotech, regarding automation of the tumor marker TPS\u00ae on all Zecen Biotech’s instruments. The development project has proceeded very well and the first phase has been completed. Thus, the last phase before launch now begins. The […]<\/p>\n","protected":false},"author":8,"featured_media":2532,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[36,38],"tags":[],"dipi_cpt_category":[],"class_list":["post-1902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breast-cancer-health-information","category-lung-cancer-health-information"],"yoast_head":"\nIDL Biotech continues its work on automating the TPS\u00ae tumor marker - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDL Biotech continues its work on automating the TPS\u00ae tumor marker - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"As previously informed, at the end of 2019, IDL Biotech signed a cooperation agreement with the Chinese company Zecen Biotech, regarding automation of the tumor marker TPS\u00ae on all Zecen Biotech’s instruments. The development project has proceeded very well and the first phase has been completed. Thus, the last phase before launch now begins. The […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-13T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-26T07:02:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/tps-cell-low-resolution.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marie\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"marie\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/\"},\"author\":{\"name\":\"marie\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\"},\"headline\":\"IDL Biotech continues its work on automating the TPS\u00ae tumor marker\",\"datePublished\":\"2021-01-13T23:00:00+00:00\",\"dateModified\":\"2021-05-26T07:02:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/\"},\"wordCount\":89,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/tps-cell-low-resolution.jpg\",\"articleSection\":[\"Breast Cancer\",\"Lung cancer\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/\",\"name\":\"IDL Biotech continues its work on automating the TPS\u00ae tumor marker - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/tps-cell-low-resolution.jpg\",\"datePublished\":\"2021-01-13T23:00:00+00:00\",\"dateModified\":\"2021-05-26T07:02:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#primaryimage\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/tps-cell-low-resolution.jpg\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/tps-cell-low-resolution.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/14\\\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDL Biotech continues its work on automating the TPS\u00ae tumor marker\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\",\"name\":\"marie\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"caption\":\"marie\"},\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/se\\\/author\\\/marie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDL Biotech continues its work on automating the TPS\u00ae tumor marker - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/","og_locale":"sv_SE","og_type":"article","og_title":"IDL Biotech continues its work on automating the TPS\u00ae tumor marker - IDL Diagnostics","og_description":"As previously informed, at the end of 2019, IDL Biotech signed a cooperation agreement with the Chinese company Zecen Biotech, regarding automation of the tumor marker TPS\u00ae on all Zecen Biotech’s instruments. The development project has proceeded very well and the first phase has been completed. Thus, the last phase before launch now begins. The […]","og_url":"https:\/\/idldiagnostics.com\/se\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_published_time":"2021-01-13T23:00:00+00:00","article_modified_time":"2021-05-26T07:02:28+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/tps-cell-low-resolution.jpg","type":"image\/jpeg"}],"author":"marie","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"marie"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#article","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/"},"author":{"name":"marie","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000"},"headline":"IDL Biotech continues its work on automating the TPS\u00ae tumor marker","datePublished":"2021-01-13T23:00:00+00:00","dateModified":"2021-05-26T07:02:28+00:00","mainEntityOfPage":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/"},"wordCount":89,"commentCount":0,"publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"image":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/tps-cell-low-resolution.jpg","articleSection":["Breast Cancer","Lung cancer"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/","url":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/","name":"IDL Biotech continues its work on automating the TPS\u00ae tumor marker - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#primaryimage"},"image":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/tps-cell-low-resolution.jpg","datePublished":"2021-01-13T23:00:00+00:00","dateModified":"2021-05-26T07:02:28+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#primaryimage","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/tps-cell-low-resolution.jpg","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/tps-cell-low-resolution.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/2021\/01\/14\/idl-biotech-continues-its-work-on-automating-the-tps-tumor-marker\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"IDL Biotech continues its work on automating the TPS\u00ae tumor marker"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]},{"@type":"Person","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000","name":"marie","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","caption":"marie"},"url":"https:\/\/idldiagnostics.com\/se\/author\/marie\/"}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=1902"}],"version-history":[{"count":2,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1902\/revisions"}],"predecessor-version":[{"id":2650,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1902\/revisions\/2650"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media\/2532"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=1902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/categories?post=1902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/tags?post=1902"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=1902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}